FOLD R&D to Revenue
Amicus Therapeutics Inc · R&D to Revenue
FOLD R&D to Revenue
Latest reported12.82%period ending
FOLD Quarterly R&D/Revenue (0.00% → 12.82%)
Latest values, visible window
High-resolution chart · PNG
FOLD r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 12.8183% | |
| 13.85% | |
| 39.336% | |
| 22.2269% | |
| 20.1662% | |
| 18.4854% | |
| 19.4862% | |
| 25.6596% | |
| 30.4383% | |
| 39.3272% | |
| 37.1935% | |
| 48.1036% | |
| 72.5016% | |
| 64.8419% | |
| 97.0123% | |
| 103.5597% | |
| 104.1897% | |
| 74.5905% | |
| 81.3856% | |
| 96.5588% | |
| 112.3592% | |
| 104.4219% | |
| 111.6402% | |
| 147.2449% | |
| 166.2272% | |
| 120.7595% | |
| 160.8452% | |
| 189.7227% | |
| 175.2757% | |
| 671.1352% | |
| 162.6543% | |
| 244.3579% | |
| 311.0055% | |
| 373.7447% | |
| 446.8427% | |
| 740.6093% | |
| 1,081.9498% | |
| 1,525.952% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -1,274.9183% | |
| 4,112.2867% | |
| 2,100.6316% | |
| 2,191.2281% | |
| 2,814.8148% | |
| 25,923.0769% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 129.0119% | |
| 180.1389% | |
| 255.7904% | |
| 236.4781% | |
| 287.5743% | |
| 186.4733% | |
| 1,426.6811% | |
| 0% | |
| 0% | |
| 0% | |
| 20.4685% | |
| 256.6456% | |
| 251.2591% | |
| 257.8159% | |
| 317.0311% | |
| 224.473% | |
| 232.414% | |
| 219.6519% | |
| 542.0404% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |